Variable | N | Crude OR (95% CI) | P- value* | Adjusted OR (95% CI) | Adjusted P-value* |
---|---|---|---|---|---|
Baseline | |||||
 Age (continuous), years | 88 | 0.96 (0.94–0.99) | 0.01 | 0.96 (0.93–0.99) | 0.01 |
 Women | 88 | 0.74 (0.30–1.78) | 0.50 |  |  |
 Daily smoking | 88 | 1.32 (0.46–3.74) | 0.59 |  |  |
 Duration of symptoms before DVT diagnosis, days | 88 | 1.02 (0.94–1.11) | 0.55 |  |  |
 DVT with pelvic vein involvement | 85 | 2.09 (0.87–5.03) | 0.10 |  |  |
 Left-sided DVT | 88 | 1.45 (0.62–3.38) | 0.39 |  |  |
 Additional catheter-directed thrombolysis | 88 | 1.57 (0.68–3.66) | 0.28 |  |  |
 Provoked DVT | 88 | 1.94 (0.76–4.95) | 0.16 |  |  |
 Villalta score (continuous) | 83 | 1.23 (1.02–1.41) | 0.03 | 1.23 (1.02–1.49) | 0.03 |
 Differences in leg circumference (continuous), cm | 65 | 0.89 (0.71–1.13) | 0.36 |  |  |
 D-dimer ≥0.5 μg/mL | 83 | 0.65 (0.10–4.09) | 0.65 |  |  |
 CRP ≥4 mg/L | 82 | 0.46 (0.10–1.98) | 0.30 |  |  |
Follow-up data, CaVenT | |||||
 Daily use of ECS | 76 | 1.48 (0.32–6.69) | 0.61 |  |  |
 Lack of iliofemoral patency | 86 | 2.88 (1.18–7.01) | 0.02 |  |  |
 Femoropoplietal reflux | 87 | 1.14 (0.47–2.77) | 0.76 |  |  |